{"version": "https://jsonfeed.org/version/1.1", "title": "Sharemaestro Newsreel: Brazil Health Information Services news", "home_page_url": "https://sharemaestro.com/newsreel/br/healthcare/health-information-services/", "feed_url": "https://sharemaestro.com/newsreel/br/healthcare/health-information-services/feed.json", "description": "Latest Health Information Services company headlines from Brazil, newest first, with source links and direct routes to company research and sentiment.", "language": "en", "items": [{"id": "source:5f54df9b0bd4d9f4985c67c08d5cb6bb9181dfcdb661a1c30f70b970d3c0bfa6", "url": "https://finance.yahoo.com/healthcare/articles/gossamer-bio-goss-reports-q2-211502157.html", "external_url": "https://finance.yahoo.com/healthcare/articles/gossamer-bio-goss-reports-q2-211502157.html", "title": "Gossamer Bio (GOSS) Reports Q2 Loss, Tops Revenue Estimates", "content_text": "Gossamer Bio (GOSS) came out with a quarterly loss of $0.2 per share versus the Zacks Consensus Estimate of a loss of $0.1. This compares to a loss of $0.17 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of -100.00%. A quarter ago, it was expected that this biopharmaceutical company would post a loss of $0.17 per share when it actually produced a loss of $0.2, delivering a surprise of -17.65%. Over the last four quarters, the company has not been able to surpass consensus EPS estimates. Gossamer Bio, which belongs", "date_published": "2026-08-13T21:15:02+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Earnings", "V2EE34"], "_sharemaestro": {"country": "Brazil", "coverage": "Provider-linked mention", "market_context": null, "companies": [{"symbol": "V2EE34", "name": "Veeva Systems Inc.", "sentiment_url": "https://sharemaestro.com/sentiment/aca76fd9-3ef1-4446-a40c-7b4d01b9ffde/"}]}}, {"id": "source:5d7859146edffa3b45b3a9b01b357fed58d488eb45767133045b49bf01a538f3", "url": "https://finance.yahoo.com/markets/stocks/articles/veeva-systems-veev-exceeds-market-214503951.html", "external_url": "https://finance.yahoo.com/markets/stocks/articles/veeva-systems-veev-exceeds-market-214503951.html", "title": "Veeva Systems (VEEV) Exceeds Market Returns: Some Facts to Consider", "content_text": "Veeva Systems (VEEV) closed at $241.51 in the latest trading session, marking a +2.08% move from the prior day. The stock exceeded the S&P 500, which registered a gain of 0.26% for the day. On the other hand, the Dow registered a loss of 0.04%, and the technology-centric Nasdaq increased by 0.54%. The stock of provider of cloud-based software services for the life sciences industry has risen by 22.52% in the past month, leading the Medical sector's gain of 2.89% and the S&P 500's gain of 2.13%. The upcoming earnings release of Veeva Systems will be of great interest to investors. The company's", "date_published": "2026-08-12T21:45:03+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Earnings", "V2EE34"], "_sharemaestro": {"country": "Brazil", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "V2EE34", "name": "Veeva Systems Inc.", "sentiment_url": "https://sharemaestro.com/sentiment/aca76fd9-3ef1-4446-a40c-7b4d01b9ffde/"}]}}, {"id": "source:b5fb12adf12b32b3e508e65101cf9d7e68458d57d40359dcff74ad48d03475b2", "url": "https://finance.yahoo.com/healthcare/articles/veeva-vault-crm-selected-eli-110300980.html", "external_url": "https://finance.yahoo.com/healthcare/articles/veeva-vault-crm-selected-eli-110300980.html", "title": "Veeva Vault CRM Selected by Eli Lilly and Company", "content_text": "PLEASANTON, Calif., Aug. 11, 2026 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that Eli Lilly and Company (Lilly) has committed to Veeva Vault CRM globally.Veeva Vault CRM Selected by Eli Lilly and Company Vault CRM is part of the Vault CRM Suite of applications that provides the technology foundation for agentic commercial, the new commercial model that leverages AI to get the right medicines to more patients. \"We are excited to expand our strategic work with Veeva by moving to Vault CRM,\" said Giuseppe Firenze, senior vice president, U.S. HCP and field engagement hub at Lilly. ", "date_published": "2026-08-11T11:03:00+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Market update", "V2EE34"], "_sharemaestro": {"country": "Brazil", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "V2EE34", "name": "Veeva Systems Inc.", "sentiment_url": "https://sharemaestro.com/sentiment/aca76fd9-3ef1-4446-a40c-7b4d01b9ffde/"}]}}, {"id": "source:57fc5bb8b8ae76eab37703766e91293fa91b1246597f3eab686cf73b5a35c204", "url": "https://finance.yahoo.com/healthcare/articles/hims-hers-health-inc-hims-215505683.html", "external_url": "https://finance.yahoo.com/healthcare/articles/hims-hers-health-inc-hims-215505683.html", "title": "Hims & Hers Health, Inc. (HIMS) Reports Q2 Loss, Tops Revenue Estimates", "content_text": "Hims & Hers Health, Inc. (HIMS) came out with a quarterly loss of $0.1 per share versus the Zacks Consensus Estimate of a loss of $0.07. This compares to earnings of $0.17 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of -42.86%. A quarter ago, it was expected that this company would post earnings of $0.04 per share when it actually produced a loss of $0.18, delivering a surprise of -550%. Over the last four quarters, the company has surpassed consensus EPS estimates just once. Hims & Hers Health, which belongs t", "date_published": "2026-08-10T21:55:05+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Earnings", "V2EE34"], "_sharemaestro": {"country": "Brazil", "coverage": "Provider-linked mention", "market_context": null, "companies": [{"symbol": "V2EE34", "name": "Veeva Systems Inc.", "sentiment_url": "https://sharemaestro.com/sentiment/aca76fd9-3ef1-4446-a40c-7b4d01b9ffde/"}]}}, {"id": "source:14e06e98466568828bda81b2de3d41e62eb4d7e606b517b527ef2be7d7e09a3a", "url": "https://finance.yahoo.com/markets/stocks/articles/behind-veeva-systems-veev-latest-210950922.html", "external_url": "https://finance.yahoo.com/markets/stocks/articles/behind-veeva-systems-veev-latest-210950922.html", "title": "What Is Behind Veeva Systems (VEEV) Latest Move?", "content_text": "Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Broker Signals On Veeva Systems Stock A fresh wave of brokerage opinions on Veeva Systems (VEEV) has put the stock back in focus for investors, as firms update their views using earnings estimate revisions and quantitative rating models. These ratings and the underlying Zacks Rank approach do not guarantee any outcome for Veeva Systems investors. They do, however, give you a structured way to compare fresh earnings expectations with the company's recent share price moves. See our ", "date_published": "2026-08-10T21:09:50+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Earnings", "V2EE34"], "_sharemaestro": {"country": "Brazil", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "V2EE34", "name": "Veeva Systems Inc.", "sentiment_url": "https://sharemaestro.com/sentiment/aca76fd9-3ef1-4446-a40c-7b4d01b9ffde/"}]}}, {"id": "source:8091f288c58626262d28cefd8089ffa377179dbd5fba100f5e3f01c639e7152b", "url": "https://finance.yahoo.com/markets/stocks/articles/wall-street-bulls-look-optimistic-133004442.html", "external_url": "https://finance.yahoo.com/markets/stocks/articles/wall-street-bulls-look-optimistic-133004442.html", "title": "Wall Street Bulls Look Optimistic About Veeva (VEEV): Should You Buy?", "content_text": "The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price. Do they really matter, though? Let's take a look at what these Wall Street heavyweights have to say about Veeva Systems (VEEV) before we discuss the reliability of brokerage recommendations and how to use them to your advantage. Veeva currently has an average brokerage recommendation (ABR) of 1.85, on a scale of 1 to 5 (Strong Buy to Strong ", "date_published": "2026-08-10T13:30:04+00:00", "authors": [{"name": "finance.yahoo.com"}], "tags": ["Earnings", "V2EE34"], "_sharemaestro": {"country": "Brazil", "coverage": "Provider-linked mention", "market_context": null, "companies": [{"symbol": "V2EE34", "name": "Veeva Systems Inc.", "sentiment_url": "https://sharemaestro.com/sentiment/aca76fd9-3ef1-4446-a40c-7b4d01b9ffde/"}]}}, {"id": "source:d57b5b18af87a6c4c97d2c4c28d98cf6f03ef2e7928b939a0fe59ecb5ec288c0", "url": "https://seekingalpha.com/news/4629554-notable-healthcare-headlines-for-the-week-eli-lilly-novo-nordisk-and-pfizer-in-focus?amp%3Butm_medium=referral&amp%3Bfeed_item_type=news", "external_url": "https://seekingalpha.com/news/4629554-notable-healthcare-headlines-for-the-week-eli-lilly-novo-nordisk-and-pfizer-in-focus?amp%3Butm_medium=referral&amp%3Bfeed_item_type=news", "title": "Notable healthcare headlines for the week: Eli Lilly, Novo Nordisk, and Pfizer in focus", "content_text": "Wall Street\u2019s major market averages ended higher on Friday after July's nonfarm payrolls surprised to the downside, showing an unexpected contraction in employment. The blue-chip Dow edged up 0.3%, the benchmark S&P 500 gained 0.62%, and the tech-focused Nasdaq Composite jumped 1.3%. The S&P 500 Health Care Index Sector (XLV [https://seekingalpha.com/symbol/XLV]) gained 1.92% during the week. The top S&P 500 healthcare gainers and losers for the last week are as follows: TOP GAINERS: Charles River Laboratories International (CRL [https://seekingalpha.com/symbol/CRL]) +15.04% Veeva Systems (VEE", "date_published": "2026-08-09T13:05:04+00:00", "authors": [{"name": "seekingalpha.com"}], "tags": ["Earnings", "V2EE34"], "_sharemaestro": {"country": "Brazil", "coverage": "Provider-linked mention", "market_context": null, "companies": [{"symbol": "V2EE34", "name": "Veeva Systems Inc.", "sentiment_url": "https://sharemaestro.com/sentiment/aca76fd9-3ef1-4446-a40c-7b4d01b9ffde/"}]}}]}